Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-marketing Non-interventional Study for Upadacitinib in Patients With Moderately to Severely Active Crohn's Disease (CD) in Japan

NCT06023030 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06023030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06023030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-marketing Non-interventional Study for Upadacitinib in Patients With Moderately to Severely Active Crohn's Disease (CD) in Japan
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
July 28, 2023
Completion date
May 31, 2027
Enrollment
240 (estimated)
Sites
104

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease